Chemistry:1cP-AL-LAD

From HandWiki

1cP-AL-LAD is a psychedelic drug of the lysergamide family related to lysergic acid diethylamide (LSD).[1][2][3][4] It is thought to act as prodrug of AL-LAD.[2][3][4] The drug has been encountered as a novel designer drug.[3][4]

Use and effects

The dose of 1cP-AL-LAD ranges from 20 to 350 μg orally, with an average dose being 100 to 225 μg.[4] Its duration is said to be 7 to 10 hours.[4] The drug is said to produce psychedelic effects that are weaker and shorter-lasting than those of LSD.[4]

Interactions

Chemistry

Analogues

Related compounds include 1cP-LSD, 1D-LSD, 1P-AL-LAD, and 1T-AL-LAD, among others.

History

1cP-AL-LAD has been sold as a designer drug.[1] It was first identified online in December 2020[3] and in France in June 2021.[4][1]

Society and culture

Canada

1cP-AL-LAD is not a controlled substance in Canada as of 2025.[5]

United States

1cP-AL-LAD is not an explicitly controlled substance in the United States.[6] However, it could be considered a controlled substance under the Federal Analogue Act if intended for human consumption.

See also

References